Global Biosurgery Market
Sizing, Segmentation, & Growth Forecast (2025-2030)
Last updated: August 2026
Report Scope: The downloadable datasheet contains market sizes in USD for the period 2025-30.
Market Breakdown: Sizes and growth rates are broken down by geography and market segment (see below for details).
1. Summary
The Global Biosurgery Market was valued at $15.8 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 6.4% CAGR, to an estimated market size of $21.5 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.
2. Market Definition
The biosurgery market comprises advanced biological and synthetic materials, including hemostatic agents, surgical sealants, adhesion barriers, and bone-graft substitutes, used to manage bleeding, facilitate tissue repair, and improve surgical outcomes. It excludes traditional mechanical closure devices like standard sutures and staples, focusing instead on products that actively participate in the physiological repair and regeneration process.
3. Trends & Demand Drivers
Several key trends are expected to significantly impact the Biosurgery Market in the period 2025-30:
- The global increase in surgical volumes driven by an aging population and rising obesity rates is a primary catalyst for market expansion.
- There is a significant technological shift from mechanical closure methods like sutures and staples toward biological and polymer-based solutions.
- The rising demand for minimally invasive surgeries (MIS) necessitates sprayable and non-adherent biosurgery products that can be applied in confined spaces.
- Integration with robotic-assisted surgery systems is enhancing the precision and delivery of advanced sealants and hemostats.
- Technological advancements in regenerative medicine and 3D printing are leading to the development of next-generation synthetic and hybrid scaffolds.
- Rising prevalence of chronic diseases such as diabetes and cardiovascular disorders is increasing the need for bioactive interventions to stimulate natural healing.
- Stringent regulatory frameworks and high product costs remain significant barriers to entry for smaller innovators in developing regions.
4. Market Breakdown
The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments:
Geographies
- North America
- Europe
- Asia-Pacific
- Rest of World
Segments
- Hemostatic Agents
- Surgical Sealants and Adhesives
- Bone-Graft Substitutes
- Adhesion Barriers and Others